Yesterday, for the first time in 2022, the Federal Reserve did not sound more hawkish. And this dovish pivot is a boon for stocks. More
Articles
Why Is Intercept Pharmaceuticals (ICPT) Stock Up Today?
Intercept Pharmaceuticals (ICPT) stock is soaring higher on Thursday after the biopharmaceutical company revealed a deal with Advanz Pharma. More
SKLZ Stock Won’t Be a Buy Until Skillz’s Marketing Expenses Fall
SKLZ stock is still not worth buying, even though Skillz now projects it will reduce its market costs to just 10% of revenue. More
Can Bitcoin Continue to Rally After the Fed’s Rate Hike?
Can Bitcoin continue to push higher despite a disappointing performance in 2022? So far, it's rallying following the Fed's rate decision. More
There’s Still Plenty to Be Bullish About in Alphabet Despite Muted Results
While YouTube's ad growth was disappointing on the surface, there are still plenty of reasons to have a positive outlook on GOOG stock. More
USD Coin Battles To Keep Its Place In the World of Stablecoins
USD Coin Battles To Keep Its Place In the World of Stablecoins. USD Coin has scored a major landmark deal with Stripe and Twitter to act as a payment mechanism for content creators. More
